Global Bispecific Antibody Market Size, Share & Industry Analysis By Therapeutic Area (Oncology, Ophthalmology, Hematology & Bleeding Disorders, Immunology Inflammation and Emerging Indications), By Mechanism Class (CD3-Engaging T-Cell Redirector Bispecific Antibodies, Dual-Pathway Receptor Blocking Bispecific Antibodies, Coagulation-Factor Mimetic Bispecific Antibodies, Dual-Checkpoint and Immune-Modulatory Bispecifics), By Route of Administration (Intravenous, Subcutaneous, Intravitreal), By End User (Hospital Oncology Centers, Specialty Infusion Clinics, Ophthalmology Clinics, Academic Hospitals) Industry Trends & Forecast 2026–2034